drugset / Trial / NCT01055041
Controller Medications in the Management of Bronchial Asthma
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to know the effect of another controller medication add on to the inhaled corticosteroid and long acting β2 agonist on clinical symptom, lung function and compliance in patients of moderate to severe persistent bronchial asthma.
Timeline
- Start
- 2008-12
- Primary completion
- 2009-06
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Budesonide | Small molecule | 200 ug | Inhaled |
| Subject | Doxofylline | Small molecule | 400 mg | Oral |
| Subject | Montelukast | Other / unclassified | 10 mg | Oral |
| Background | formeterol | Unknown | 6 ug | Inhaled |